|
TP53BP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.164580E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.353240E-01 |
| Normal-vs-Stage2 |
2.154200E-02 |
| Normal-vs-Stage3 |
1.885250E-01 |
| Normal-vs-Stage4 |
1.825990E-01 |
| Stage1-vs-Stage2 |
6.872400E-02 |
| Stage1-vs-Stage3 |
7.619000E-01 |
| Stage1-vs-Stage4 |
8.950400E-01 |
| Stage2-vs-Stage3 |
6.928300E-02 |
| Stage2-vs-Stage4 |
9.363500E-02 |
| Stage3-vs-Stage4 |
9.260200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.488440E-01 |
| Normal-vs-AfricanAmerican |
7.307400E-01 |
| Normal-vs-Asian |
4.385400E-01 |
| Caucasian-vs-AfricanAmerican |
1.650830E-01 |
| Caucasian-vs-Asian |
2.954600E-01 |
| AfricanAmerican-vs-Asian |
6.226600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.533700E-02 |
| Normal-vs-Female |
1.330040E-01 |
| Male-vs-Female |
5.323200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.350600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.101030E-01 |
| Normal-vs-Age(61-80Yrs) |
4.050400E-02 |
| Normal-vs-Age(81-100Yrs) |
4.559200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.868200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.676300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.367200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.164200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.650600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.863200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.760200E-02 |
| Classical-VS-Follicular |
6.63913368725844E-14 |
| Classical-VS-Other |
8.688000E-02 |
| Classical-VS-Normal |
4.136000E-01 |
| Tall-VS-Follicular |
2.608600E-04 |
| Tall-VS-Other |
1.219390E-01 |
| Tall-VS-Normal |
1.381960E-01 |
| Follicular-VS-Other |
6.568400E-01 |
| Follicular-VS-Normal |
9.160200E-04 |
| Other-VS-Normal |
4.165700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.037900E-02 |
| Normal-vs-N1 |
2.585800E-01 |
| N0-vs-N1 |
2.356200E-02 |
|
|
